India bans export of Covid vaccine: Health Ministry holds meeting
Published: 01:54 PM, 4 January 2021 Updated: 04:19 PM, 4 January 2021
The Ministry of Health and Family Welfare of Bangladesh has met to discuss the issue of India's ban on the export of coronavirus vaccine developed by Oxford-AstraZeneca.
The meeting presided over by Secretary of the Health Service Division Mohammad Abdul Mannan, was begin at the secretariat around 11:30 am on Monday to decide what to do in this regard.
India's Directorate General of Drug Administration (DGDA) ordered Serum Institute of India, which has been contracted to make 1 billion doses of the vaccine for developing nations, not to export of the vaccine for several months.
According to an agreement - which was signed between Serum Institute, Beximco Pharmaceuticals and the government of Bangladesh - 3 crore doses of vaccine were to be given to Bangladesh in six months at the rate of 5 million doses per month from the first month of production.
Besides, other officials including the director-general of the Directorate General of Health Services(old building) and the director-general of the Directorate General of Drug Administration (DGDA) are also present at the meeting.
Before leaving for the meeting, the Secretary of the Health Service Division told reporters, "We will make a decision after discussing the matter."